|
|
About the Participants
|
|
|
|
|
| Left to Right: Fred Modell, Vicki Modell, Dennis Jackman, Peter Turner |
The Jeffrey Modell Foundation
The Jeffrey Modell Foundation was established by Vicki and Fred Modell in memory of their son Jeffrey, who died at the age of 15 of a Primary Immunodeficiency. The Foundation is dedicated to early and precise diagnosis, meaningful treatments, and ultimately cures of Primary Immunodeficiencies.
The Foundation’s Focus:
- To affirm its absolute commitment to clinical and basic research in order to better understand and treat Primary Immunodeficiencies.
- To serve as a national and international source for the dissemination of information and education into the diagnosis and treatment of genetic immunodeficiencies.
- To serve as a tireless, compassionate advocate on behalf of patients and families to assure their access to excellent and comprehensive care.
- To promote public awareness of the Primary Immunodeficiency diseases through programs involving our lawmakers as well as lay, scientific, and medical communities.
- To affirm its commitment to turn pain, despair and suffering of immunodeficient children and adults into comfort and hope.
Jeffrey Modell Foundation
747 Third Avenue
New York, NY 10017
Phone: 212 819 0200
Fax: 212 764 4180
www.jmfworld.org
ZLB Behring
ZLB Behring is one of the world’s leading pharmaceutical companies specializing in the manufacture of plasma products. Its comprehensive line of therapies include products for the treatment of hemophilia and other coagulation disorders, immunoglobulins for the prevention and treatment of immune disorders, treatments that inhibit the formation of blood clots, wound-healing agents used during major surgical procedures, and plasma expanders for the treatment of a variety of conditions such as shock, burns and circulatory disorders. Additionally, ZLB Behring operates one of the world’s largest, fully-owned plasma collection networks.
ZLB Behring is committed to developing the next generation of therapeutic proteins to meet the demands of the evolving market. Products under development include subcutaneous immunoglobulin treatment for primary immune deficiency and fibrin dressings for use in cases of severe hemorrhage.
At plants located in Bern, Switzerland; Marburg, Germany; and Kankakee, Illinois, ZLB Behring manufactures therapies in accordance with international safety and quality standards. The products are distributed worldwide.
ZLB Behring is a subsidiary of CSL Limited, a pharmaceutical company which operates worldwide from headquarters in Melbourne, Australia.
ZLB Behring LLC
1020 First Avenue
P.O. Box 61501
King of Prussia, PA 19406-0901
Phone: 610 878 4000
Fax: 610 878 4009
www.zlbbehring.com |
Return to Top
Previous:
Looking Forward
Back to Beginning |
|